Top videos
The experts at stalbertphysiotherapy.com have now served over 12,420 patients in the St. Albert and Edmonton communities. Since 1992, they have helped patients find relief from pain from physical ailments caused from such things as disease, injuries, and deformities. The team of rehabilitation therapists are now offering no obligation appointments so potential patients can find out more about how the service might help them. Visit - https://stalbertphysiotherapy.com/contact/
Source ABC7, 24 November 2009 An initial single-arm Phase II trial (ACT II) has reported promising preliminary data in 23 patients who received CDX-110 vaccine. Median time to disease progression was 16.6 months and estimated median overall survival was 33.1 months. This compared favorably with data for a historical control group in which median time to progression was 6.4 months and median overall survival was 15.2 months. The study was sponsored by Celldex Therapeutics Inc. of Phillipsburg, NJ